Table 1

Association of Hp1γ expression with patient pathological features
Variable Number Nucleus Cytoplasm Total
Mean intensity (SD) p-value Mean intensity (SD) p-value Mean intensity (SD) p-value
Gleason
 3+3 or 3+4 47 8.77 (2.5) 0.018 3.02 (0.8) 0.095 11.8 (3.2) 0.042
 4+3 or 4+4 or 4+5 12 10.74 (2.5) 4.1 (2.0) 14.9 (4.5)
Stage
 T2 40 8.62 (2.7) 0.238 2.86 (0.9) 0.039 11.48 (3.4) 0.12
 T3 12 9.46 (1.6) 3.47 (0.7) 12.92 (2.2)
 T4 11 10.0 (2.9) 3.77 (2.0) 13.78 (4.7)
Tumor Volume
 <5 7 9.59 (1.8) 0.776 3.07 (0.8) 0.156 12.67 (2.4) 0.879
 5-20 36 8.84 (2.9) 3.06 (1.4) 11.91 (4.0)
 >20 20 9.09 (2.4) 4.01 (2.5) 12.03 (3.1)
SV involvement
 No 49 8.96 (2.6) 0.684 3.04 (1.2) 0.182 12.01 (3.7) 0.468
 Yes 11 9.30 (2.5) 4.76 (3.0) 12.29 (3.3)
Margins Positive
 No 41 9.40 (2.6) 0.105 3.22 (1.3) 0.469 12.55 (3.7) 0.876
 Yes 21 8.25 (2.5) 3.0 (1.0) 11.25 (3.4)
Extracapsular
 No 46 8.91 (2.8) 0.633 3.39 (2.0) 0.875 11.83 (3.8) 0.471
 Yes 17 9.26 (2.0) 3.31 (0.9) 12.57 (2.8)
Metastasis
 No 52 8.95 (2.7) 0.723 3.11 (1.2) 0.640 12.07 (3.7) 0.682
 Yes 12 9.25 (2.04) 4.50 (3.1) 11.97 (2.7)

Slezak et al.

Slezak et al. BMC Cancer 2013 13:148   doi:10.1186/1471-2407-13-148

Open Data